Journal
CYTOKINE
Volume 144, Issue -, Pages -Publisher
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.cyto.2021.155549
Keywords
IL-6; Metabolic disease; Gp130 ligands
Funding
- National Health & Medical Research Council of Australia [APP1194141, APP1116936]
Ask authors/readers for more resources
Metabolic diseases are common and using gp130 receptor ligands as a therapeutic strategy can be effective in treating them.
Metabolic disease is highly prevalent. Here we discuss the therapeutic utility of using gp130 receptor ligands as a therapeutic strategy to treat metabolic disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
